Make a Difference with a Donation

Clinical Trials & Studies

Included on this page is clinical trial information and other test information.  Please click on the link to learn more details about the trial, its purpose, who may participate, locations, and phone numbers for more information.  Please seek advice from your medical teams about the clinical trials or studies you are intrested in. The items are listed in date order & updated periodically:


Benralizumab for Eosinophilic Gastritis (ANTI-IL5RA)

Study Start Date: March 30, 2018
Cincinnati Children’s Hospital
How to Participate: NCT03473977
Study Coordinator: Tal Cohen
Phone: 513-517-1074
Email: Tal.cohen@cchmc.org


A Study of AK002 in Patients With Eosinophilic Gastritis With or Without Eosinophilic Gastroenteritis (ENIGMA)

Study Start Date: April 12, 2018
Locations:
Arizona
Phoenician Centers for Research and Innovation Recruiting
Phoenix, Arizona, United States, 85021
Contact: Kenneth Boren 480-346-9514
California
Ventura Clinical Trials Recruiting
Ventura, California, United States, 93003
Contact: Alon Steinberg 805-339-0549
Florida
Riverside Clinical Research Recruiting
Edgewater, Florida, United States, 32132
Contact: Susan Hole 386-428-7730
Illinois
Northwestern Recruiting
Chicago, Illinois, United States, 60611
Contact: Ikuo Hirano 312-695-4054
Iowa
University of Iowa Recruiting
Iowa City, Iowa, United States, 52242
Contact: Yehudith Assouline-Dayan 319-335-9767
Massachusetts
Tufts Medical Center Recruiting
Boston, Massachusetts, United States, 02111
Contact: John Leung 617-636-4941
Minnesota
Mayo Clinic Recruiting
Rochester, Minnesota, United States, 55905
Contact: Joseph Murray 507-284-2631
New York
Icahn School of Medicine at Mount Sinai Recruiting
New York, New York, United States, 10029
Contact: Mirna Chehade 212-241-7099
North Carolina
University of North Carolina – Chapel Hill Recruiting
Chapel Hill, North Carolina, United States, 27599
Contact: Evan Dellon 919-966-2996
Ohio
Cincinnati Children’s Hospital Recruiting
Cincinnati, Ohio, United States, 45229
Contact: Marc Rothenberg 513-803-5074
Tennessee
Vanderbilt University Recruiting
Nashville, Tennessee, United States, 37212
Contact: Michael Vaezi 615-875-7502
Utah
University of Utah Recruiting
Salt Lake City, Utah, United States, 84132
Contact: Kathryn Peterson 801-587-9050
For More Information: NCT03496571


Effect of Elemental Diet on Adult Patients with Eosinophilic Gastroenteritis (ELEMENT)
How to Participate: You must contact the study coordinator directly:
Northwestern University, Chicago
Study Coordinator: Angelika Zalewski, BS
Phone: 312-695-4054
Email: angelika.zalewski@northwestern.edu


Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE)

Study Start Date: June 2017

Adare Pharmaceuticals, Inc.
How to Participate: NCT03191864


Eosinophilic Esophagitis (EoE) Intervention Trial-Randomized 1 Food Elimination vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids

Study Start Date: January 2016

Children’s Hospital Medical Center, Cincinnati
How to Participate: NCT02610816


Cytosponge and Dietary Therapy in EoE

Study Start Date: November 2015

Mayo Clinic
How to Participate: NCT02599558


A Placebo- Controlled Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved

Study Start Date: November 2015

Shire
How to Participate:  NCT02605837


Milk Patch for Eosinophilic Esophagitis (SMILEE)

Study Start Date: October 2015

Children’s Hospital of Philadelphia
How to Participate: NCT02579876


OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Study Start Date: June 2015

National Institute of Allergy and Infectious Diseases (NIAID)
How to Participate: NTC02523118


Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis

Study Start Date: February 2015

University of Tennessee
How to Participate: NTC02371941


Study of Dupilumab in Adult Patients With Active Eosinophilic Esophagitis (EoE)

Study Start Date: February 2015

Regeneron Pharmaceuticals
How to Participate: NTC02379052


Food Antigen in Eosinophilic Esophagitis (EoE)

Study Start Date: April 2015

Mayo Clinic
How to Participate: NCT02434705


The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis (EoE)

Study Start Date: January 2015

Mayo Clinic
How to Participate:  NCT02353078


EndoFLIP Use in Upper GI Tract Stenosis

Study Start Date: December 2014

University of Pennsylvania
How to Participate: NCT02354716


Esophageal Absorption in EoE

Study Start Date: November 2014

Mayo Clinic
How to Participate: NCT023144554


Fibrostenotic Eosinophilic Esophagitis: Assessment Tools

Study Start Date: September 2014

University of Colorado, Denver
How to Participate: NCT02453126


Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis (EoE)

Study Start Date: August 2014

Mayo Clinic
How to Participate: NCT02227836



Placebo- Controlled Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved

Study Start Date: November 2015

Shire
How to Participate:  NCT02605837


Budesonide Effervescent Tablet vs. Placebo in Active Eosinophilic Esophagitis (EOS-1)

Study Start Date: April 2015

Dr. Falk Pharma GmbH
How to Participate: NCT02434029


Esophageal String Test in Eosinophilic Esophagitis

Study Start Date: December 2013

University of Colorado, Denver
How to Participate: NTC02008903


Mucosal Impedance and Eosinophilic Esophagitis (EoE)

Study Start Date: September 2013

Mayo Clinic
How to Participate: NTC01953575


Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis

Study Start Date: December 2013

University of North Carolina, Chapel Hill
How to Participate: NTC02019758


Nasal Nitric Oxide Levels in EoE

Study Start Date: August 2013

Mayo Clinic
How to Participate: NCT01929824


Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

Study Start Date: January 2013

Children’s Hospital Medical Center, Cincinnati
How to Participate: NCT01808196


Molecular Basis of Food Allergy

Study Start Date: April 2013

Children’s Hospital of Philadelphia
How to Participate: NTC01832324


Cytosponge Protocol IRB 11-006429

Study Start Date: April 2012

University of Cambridge
How to Participate: NTC01585103


Eosinophilic Esophagitis Databank (CoFAR5)

Study Start Date: March 2011

Children’s Hospital Medical Center, Cincinnati
How to Participate: NTC01323803


Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index (EEsAI)

Study Start Date: July 2009

University Hospital Inselspital, Berne
How to Participate: NTC00939263


Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

Study Start Date: December 2005

Children’s Hospital Medical Center, Cincinnati
How to Participate: NTC00267501


SSL Certificate security seal